Glenmark US Launches Sodium Bicarbonate Injection

US division has rolled out a sodium bicarbonate injection used to treat people suffering from metabolic acidosis, which means the body is making too much acid due to issues like kidney failure, diabetes, dehydration, shock, or cardiac arrest. This formulation matches Abbott Labs' product in both safety and effectiveness, offering hospitals a reliable alternative for urgent care. With the injectable market for this product size worth around $63.8 million in the US, Glenmark’s move expands its presence in high-demand critical care medicines, focusing on affordable and quality solutions for patients in need. Disclaimer: This post is for informational purposes only and not a recommendation to buy or sell any securities. I, or my family, associates, or relatives, may have a financial interest in the securities mentioned.